fitusiran (ALN-AT3) - Sanofi
Advate (octocog alfa) - Takeda
Hemlibra (emicizumab-kxwh) - Roche
https://library.ehaweb.org/eha/2024/eha2024-congress/419799/henri.spronk.intrinsic.activated.thrombin.generation.for.efficacy.and.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Ace_id%3D2552%2Aot_id%3D29188%2Amarker%3D5101%2Afeatured%3D18527
 
Henri Spronk; René van Oerle; Floor Heubel-Moenen; Peter Giesen; Dave Hellenbrand; Amaury Monard; Paola van der Meijden; Tilman Hackeng; Hugo ten Cate; Yvonne Henskens
 
May 15, 2024
 
Next